| Financial Year |
March 31 2023 |
| Monetary Funds |
13,129,898,356.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
232,491,313.00 |
| Advances to Suppliers |
162,482,124.00 |
| Other Receivables |
1,742,893,174.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
36,955,287,724.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
808,043,993.00 |
| Other Current Assets |
2,264,525,625.00 |
| Total Current Assets |
55,295,622,309.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
146,839,419.00 |
| Long-term Equity Investment |
347,873,577.00 |
| Investment Properties |
7,929,237,041.00 |
| Fixed Assetes |
2,854,014,053.00 |
| Under-construction Projects |
1,092,681.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,218,224.00 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,509,995.00 |
| Deferred Income Tax Assets |
1,312,893,908.00 |
| Other Non-Current Assets |
10,566,000.00 |
| Sub-Total of Non-Current Assets |
12,695,609,066.00 |
| Total Assets |
67,991,231,375.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,265,993,723.00 |
| Accounts Received In Advance |
228,089,416.00 |
| Employee Compensation Payable |
113,594,090.00 |
| Taxes Payable |
1,465,589,236.00 |
| Interest Payable |
-- |
| Dividend Payable |
276,162,190.00 |
| Other payables |
2,417,838,513.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,092,334,295.00 |
| Other Current Liabilities |
147,458.00 |
| Sub-Total of Current Liabilities |
29,037,287,392.00 |
| Long-term Loans |
10,310,264,740.00 |
| Bonds Payable |
6,774,493,079.00 |
| Long-Term Accounts Payable |
5,733,347,571.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,946,093,114.00 |
| Total Liabilities |
51,983,380,506.00 |
| Paid-In Capital(Or Share Stock) |
3,367,020,000.00 |
| Capital Surplus |
3,714,698,888.00 |
| Surplus Reserve |
1,071,254,548.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,652,245,269.00 |
| Minority Stockholder's Interest |
3,188,475,658.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,819,375,211.00 |
| Owner's Equity（Stockholder's Equity） |
16,007,850,869.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
67,991,231,375.00 |
